{"url":"https://lda.gov/api/v1/filings/82a83572-365f-4d5f-ab50-f367c653b91c/","filing_uuid":"82a83572-365f-4d5f-ab50-f367c653b91c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/82a83572-365f-4d5f-ab50-f367c653b91c/print/","filing_document_content_type":"text/html","income":null,"expenses":"1662000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Charles Clapton","dt_posted":"2025-04-21T16:51:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"333 LAKESIDE DRIVE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"FOSTER CITY","registrant_state":"CA","registrant_zip":"94404","registrant":{"id":287177,"url":"https://lda.gov/api/v1/registrants/287177/","house_registrant_id":37026,"name":"GILEAD SCIENCES, INC.","description":null,"address_1":"333 LAKESIDE DRIVE","address_2":null,"address_3":null,"address_4":null,"city":"FOSTER CITY","state":"CA","state_display":"California","zip":"94404","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABIGAIL STRAYER","contact_telephone":"+1 240-619-9258","dt_updated":"2026-07-29T14:24:27.706440-04:00"},"client":{"id":176597,"url":"https://lda.gov/api/v1/clients/176597/","client_id":12,"name":"GILEAD SCIENCES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"International trade and protection of intellectual property; TRIPS Waiver; global supply chain issues, including the Medical Supply Chain Resiliency Act; compulsory licensing and other IP issues in multiple countries.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocate on drug pricing proposals and proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Advocate in favor of 340B program reforms and changes to Notice of Benefit and Payment Parameters (NBPP). Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments and therapies, including: manufacturing, clinical trials, reimbursement and coverage.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73330,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocate for provisions modifying the Inflation Reduction Act. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies and prevention including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to hospital inpatient payments, Medicaid Drug Rebate Program, and Value-Based Purchasing arrangements including changes to best price.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71381,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"D","last_name":"BOYD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73330,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114061,"prefix":null,"prefix_display":null,"first_name":"GRACE","nickname":null,"middle_name":null,"last_name":"RODDEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139522,"prefix":"mr","prefix_display":"MR.","first_name":"BILL","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144583,"prefix":null,"prefix_display":null,"first_name":"JAIMON","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149783,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Legislative and regulatory proposals to change international and domestic corporate tax law and policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67697,"prefix":null,"prefix_display":null,"first_name":"CHARLES M.","nickname":null,"middle_name":null,"last_name":"CLAPTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60986,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PULLIAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}